[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"footer-top-cryptos-10":3,"kalshi-series-detail-KXFDAAPPROVE":80},[4,11,19,27,34,41,48,56,64,72],{"cmcId":5,"symbol":6,"name":7,"logo":8,"rank":5,"price":9,"change24h":10},1,"BTC","Bitcoin","https://s2.coinmarketcap.com/static/img/coins/64x64/1.png",84239.37989253223,-0.13666573,{"cmcId":12,"symbol":13,"name":14,"logo":15,"rank":16,"price":17,"change24h":18},1027,"ETH","Ethereum","https://s2.coinmarketcap.com/static/img/coins/64x64/1027.png",2,2686.674656552982,0.46965419,{"cmcId":20,"symbol":21,"name":22,"logo":23,"rank":24,"price":25,"change24h":26},825,"USDT","Tether USDt","https://s2.coinmarketcap.com/static/img/coins/64x64/825.png",3,0.9996008402436136,-0.02790284,{"cmcId":28,"symbol":29,"name":29,"logo":30,"rank":31,"price":32,"change24h":33},1839,"BNB","https://s2.coinmarketcap.com/static/img/coins/64x64/1839.png",4,778.5035859763535,1.50773745,{"cmcId":35,"symbol":36,"name":36,"logo":37,"rank":38,"price":39,"change24h":40},52,"XRP","https://s2.coinmarketcap.com/static/img/coins/64x64/52.png",5,1.5279001752022072,2.35936829,{"cmcId":42,"symbol":43,"name":43,"logo":44,"rank":45,"price":46,"change24h":47},3408,"USDC","https://s2.coinmarketcap.com/static/img/coins/64x64/3408.png",6,0.999816604449974,-0.01603437,{"cmcId":49,"symbol":50,"name":51,"logo":52,"rank":53,"price":54,"change24h":55},5426,"SOL","Solana","https://s2.coinmarketcap.com/static/img/coins/64x64/5426.png",7,116.85902696589734,2.1897679,{"cmcId":57,"symbol":58,"name":59,"logo":60,"rank":61,"price":62,"change24h":63},1958,"TRX","TRON","https://s2.coinmarketcap.com/static/img/coins/64x64/1958.png",8,0.3404515383406671,0.07913773,{"cmcId":65,"symbol":66,"name":67,"logo":68,"rank":69,"price":70,"change24h":71},1437,"ZEC","Zcash","https://s2.coinmarketcap.com/static/img/coins/64x64/1437.png",9,1549.534763236853,2.26104618,{"cmcId":73,"symbol":74,"name":75,"logo":76,"rank":77,"price":78,"change24h":79},32196,"HYPE","Hyperliquid","https://s2.coinmarketcap.com/static/img/coins/64x64/32196.png",10,94.17179401632826,0.94212131,{"_id":81,"activeEventCount":31,"category":82,"contractUrl":83,"eventCount":31,"feeMultiplier":5,"feeType":84,"frequency":85,"lastEventDate":86,"lastUpdated":87,"settlementSources":88,"slug":92,"status":93,"tags":94,"ticker":81,"title":97,"volume":98,"events":99},"KXFDAAPPROVE","Science","https://assets.kalshi.com/regulatory/product-certifications/FDAAPPROVALDATE.pdf","quadratic","one_off",["Date","2027-04-08T14:00:00.000Z"],["Date","2026-09-24T04:31:31.282Z"],[89],{"name":90,"url":91},"Food and Drug Administration","https://www.fda.gov/news-events/fda-newsroom/press-announcements","will-the-fda-approve-drug-kxfdaapprove","active",[95,96],"science","kxfdaapprove","Will the FDA approve drug?",0,[100,163,241,285],{"_id":101,"avgSpreadCents":102,"category":82,"endDate":103,"eventTicker":101,"lastUpdated":104,"liquidity":105,"marketCount":38,"markets":106,"mutuallyExclusive":117,"openInterest":105,"seriesTicker":81,"slug":154,"status":93,"strikeDate":105,"strikePeriod":105,"subTitle":155,"title":156,"topOutcomes":157,"volume":98,"volume24h":105},"KXFDAAPPROVE-V940",16,["Date","2027-04-08T14:00:00.000Z"],["Date","2026-09-24T20:31:19.906Z"],null,[107,118,126,136,147],{"ticker":108,"title":109,"yesSubTitle":110,"noSubTitle":110,"yesBidDollars":98,"yesAskDollars":5,"noBidDollars":98,"noAskDollars":5,"lastPriceDollars":98,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":111,"expirationTime":112,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":115,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":98,"spreadCents":105,"spreadQuality":105,"liquidityScore":98},"KXFDAAPPROVE-V940-27APR01","Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Apr 1, 2027?","Before Apr 1, 2027","2027-04-01T03:59:00Z","2027-04-08T14:00:00Z","binary","custom","If the FDA approves intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma for marketing before Apr 1, 2027, then the market resolves to Yes.",true,false,{"ticker":119,"title":120,"yesSubTitle":121,"noSubTitle":121,"yesBidDollars":98,"yesAskDollars":5,"noBidDollars":98,"noAskDollars":5,"lastPriceDollars":122,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":123,"expirationTime":124,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":125,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":122,"spreadCents":105,"spreadQuality":105,"liquidityScore":98},"KXFDAAPPROVE-V940-27JUL01","Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Jul 1, 2027?","Before Jul 1, 2027",0.2,"2027-07-01T03:59:00Z","2027-07-08T14:00:00Z","If the FDA approves intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma for marketing before Jul 1, 2027, then the market resolves to Yes.",{"ticker":127,"title":128,"yesSubTitle":129,"noSubTitle":129,"yesBidDollars":98,"yesAskDollars":130,"noBidDollars":131,"noAskDollars":5,"lastPriceDollars":132,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":133,"expirationTime":134,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":135,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":132,"spreadCents":105,"spreadQuality":105,"liquidityScore":98},"KXFDAAPPROVE-V940-27OCT01","Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Oct 1, 2027?","Before Oct 1, 2027",0.99,0.01,0.68,"2027-10-01T03:59:00Z","2027-10-08T14:00:00Z","If the FDA approves intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma for marketing before Oct 1, 2027, then the market resolves to Yes.",{"ticker":137,"title":138,"yesSubTitle":139,"noSubTitle":139,"yesBidDollars":140,"yesAskDollars":5,"noBidDollars":98,"noAskDollars":141,"lastPriceDollars":142,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":143,"expirationTime":144,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":145,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":142,"spreadCents":102,"spreadQuality":146,"liquidityScore":98},"KXFDAAPPROVE-V940-28JAN01","Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Jan 1, 2028?","Before Jan 1, 2028",0.84,0.16,0.95,"2028-01-01T04:59:00Z","2028-01-08T15:00:00Z","If the FDA approves intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma for marketing before Jan 1, 2028, then the market resolves to Yes.","wide",{"ticker":148,"title":149,"yesSubTitle":150,"noSubTitle":150,"yesBidDollars":98,"yesAskDollars":5,"noBidDollars":98,"noAskDollars":5,"lastPriceDollars":98,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":151,"expirationTime":152,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":153,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":98,"spreadCents":105,"spreadQuality":105,"liquidityScore":98},"KXFDAAPPROVE-V940-28JUL01","Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Jul 1, 2028?","Before Jul 1, 2028","2028-07-01T03:59:00Z","2028-07-08T14:00:00Z","If the FDA approves intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma for marketing before Jul 1, 2028, then the market resolves to Yes.","will-the-fda-approve-intismeran-autogene-v940-mrna-4157-kxfdaapprove-v940","intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma","Will the FDA approve intismeran autogene (V940/mRNA-4157)?",[158,160,162],{"name":138,"probability":159,"ticker":137,"volume":98},0.9199999999999999,{"name":109,"probability":161,"ticker":108,"volume":98},0.5,{"name":120,"probability":161,"ticker":119,"volume":98},{"_id":164,"avgSpreadCents":165,"category":82,"endDate":166,"eventTicker":164,"lastUpdated":167,"liquidity":105,"marketCount":45,"markets":168,"mutuallyExclusive":117,"openInterest":105,"seriesTicker":81,"slug":231,"status":93,"strikeDate":105,"strikePeriod":105,"subTitle":232,"title":233,"topOutcomes":234,"volume":98,"volume24h":105},"KXFDAAPPROVE-MDMA",17,["Date","2027-01-08T15:00:00.000Z"],["Date","2026-09-24T20:31:19.883Z"],[169,180,188,200,212,222],{"ticker":170,"title":171,"yesSubTitle":172,"noSubTitle":172,"yesBidDollars":173,"yesAskDollars":174,"noBidDollars":175,"noAskDollars":176,"lastPriceDollars":141,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":177,"expirationTime":178,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":179,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":141,"spreadCents":53,"spreadQuality":146,"liquidityScore":98},"KXFDAAPPROVE-MDMA-27JAN01","Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2027?","Before Jan 1, 2027",0.07,0.14,0.86,0.93,"2027-01-01T04:59:00Z","2027-01-08T15:00:00Z","If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2027, then the market resolves to Yes.",{"ticker":181,"title":182,"yesSubTitle":139,"noSubTitle":139,"yesBidDollars":183,"yesAskDollars":184,"noBidDollars":185,"noAskDollars":186,"lastPriceDollars":184,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":143,"expirationTime":144,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":187,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":184,"spreadCents":61,"spreadQuality":146,"liquidityScore":98},"KXFDAAPPROVE-MDMA-28JAN01","Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2028?",0.31,0.39,0.61,0.69,"If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2028, then the market resolves to Yes.",{"ticker":189,"title":190,"yesSubTitle":191,"noSubTitle":191,"yesBidDollars":192,"yesAskDollars":193,"noBidDollars":194,"noAskDollars":195,"lastPriceDollars":196,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":197,"expirationTime":198,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":199,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":196,"spreadCents":61,"spreadQuality":146,"liquidityScore":98},"KXFDAAPPROVE-MDMA-29JAN01","Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2029?","Before Jan 1, 2029",0.48,0.56,0.44,0.52,0.53,"2029-01-01T04:59:00Z","2029-01-08T15:00:00Z","If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2029, then the market resolves to Yes.",{"ticker":201,"title":202,"yesSubTitle":203,"noSubTitle":203,"yesBidDollars":204,"yesAskDollars":205,"noBidDollars":206,"noAskDollars":207,"lastPriceDollars":161,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":208,"expirationTime":209,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":210,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":161,"spreadCents":211,"spreadQuality":146,"liquidityScore":98},"KXFDAAPPROVE-MDMA-30JAN01","Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2030?","Before Jan 1, 2030",0.51,0.98,0.02,0.49,"2030-01-01T04:59:00Z","2030-01-08T15:00:00Z","If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2030, then the market resolves to Yes.",47,{"ticker":213,"title":214,"yesSubTitle":215,"noSubTitle":215,"yesBidDollars":195,"yesAskDollars":216,"noBidDollars":217,"noAskDollars":192,"lastPriceDollars":196,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":218,"expirationTime":219,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":220,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":196,"spreadCents":221,"spreadQuality":146,"liquidityScore":98},"KXFDAAPPROVE-MDMA-31JAN01","Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2031?","Before Jan 1, 2031",0.75,0.25,"2031-01-01T04:59:00Z","2031-01-08T15:00:00Z","If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2031, then the market resolves to Yes.",23,{"ticker":223,"title":224,"yesSubTitle":225,"noSubTitle":225,"yesBidDollars":204,"yesAskDollars":226,"noBidDollars":227,"noAskDollars":207,"lastPriceDollars":226,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":228,"expirationTime":229,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":230,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":226,"spreadCents":53,"spreadQuality":146,"liquidityScore":98},"KXFDAAPPROVE-MDMA-32JAN01","Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2032?","Before Jan 1, 2032",0.58,0.42,"2032-01-01T04:59:00Z","2032-01-08T15:00:00Z","If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2032, then the market resolves to Yes.","will-the-fda-approve-mdma-for-ptsd-kxfdaapprove-mdma","MDMA for PTSD","Will the FDA approve MDMA for PTSD?",[235,237,239],{"name":202,"probability":236,"ticker":201,"volume":98},0.745,{"name":214,"probability":238,"ticker":213,"volume":98},0.635,{"name":224,"probability":240,"ticker":223,"volume":98},0.5449999999999999,{"_id":242,"avgSpreadCents":61,"category":82,"endDate":243,"eventTicker":242,"lastUpdated":244,"liquidity":105,"marketCount":31,"markets":245,"mutuallyExclusive":117,"openInterest":105,"seriesTicker":81,"slug":275,"status":93,"strikeDate":105,"strikePeriod":105,"subTitle":276,"title":277,"topOutcomes":278,"volume":98,"volume24h":105},"KXFDAAPPROVE-CAG",["Date","2026-10-08T14:00:00.000Z"],["Date","2026-09-24T20:31:21.601Z"],[246,255,263,269],{"ticker":247,"title":248,"yesSubTitle":249,"noSubTitle":249,"yesBidDollars":98,"yesAskDollars":250,"noBidDollars":251,"noAskDollars":5,"lastPriceDollars":131,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":252,"expirationTime":253,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":254,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":131,"spreadCents":105,"spreadQuality":105,"liquidityScore":98},"KXFDAAPPROVE-CAG-26OCT01","Will the FDA approve CagriSema before Oct 1, 2026?","Before Oct 1, 2026",0.03,0.97,"2026-10-01T03:59:00Z","2026-10-08T14:00:00Z","If the FDA approves CagriSema for marketing before Oct 1, 2026, then the market resolves to Yes.",{"ticker":256,"title":257,"yesSubTitle":172,"noSubTitle":172,"yesBidDollars":258,"yesAskDollars":259,"noBidDollars":260,"noAskDollars":261,"lastPriceDollars":259,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":177,"expirationTime":178,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":262,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":259,"spreadCents":53,"spreadQuality":146,"liquidityScore":98},"KXFDAAPPROVE-CAG-27JAN01","Will the FDA approve CagriSema before Jan 1, 2027?",0.67,0.74,0.26,0.33,"If the FDA approves CagriSema for marketing before Jan 1, 2027, then the market resolves to Yes.",{"ticker":264,"title":265,"yesSubTitle":121,"noSubTitle":121,"yesBidDollars":259,"yesAskDollars":266,"noBidDollars":267,"noAskDollars":260,"lastPriceDollars":266,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":123,"expirationTime":124,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":268,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":266,"spreadCents":61,"spreadQuality":146,"liquidityScore":98},"KXFDAAPPROVE-CAG-27JUL01","Will the FDA approve CagriSema before Jul 1, 2027?",0.82,0.18,"If the FDA approves CagriSema for marketing before Jul 1, 2027, then the market resolves to Yes.",{"ticker":270,"title":271,"yesSubTitle":139,"noSubTitle":139,"yesBidDollars":272,"yesAskDollars":140,"noBidDollars":141,"noAskDollars":273,"lastPriceDollars":140,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":143,"expirationTime":144,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":274,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":140,"spreadCents":61,"spreadQuality":146,"liquidityScore":98},"KXFDAAPPROVE-CAG-28JAN01","Will the FDA approve CagriSema before Jan 1, 2028?",0.76,0.24,"If the FDA approves CagriSema for marketing before Jan 1, 2028, then the market resolves to Yes.","will-the-fda-approve-cagrisema-kxfdaapprove-cag","CagriSema","Will the FDA approve CagriSema?",[279,281,283],{"name":271,"probability":280,"ticker":270,"volume":98},0.8,{"name":265,"probability":282,"ticker":264,"volume":98},0.78,{"name":257,"probability":284,"ticker":256,"volume":98},0.7050000000000001,{"_id":286,"avgSpreadCents":287,"category":82,"endDate":288,"eventTicker":286,"lastUpdated":289,"liquidity":105,"marketCount":24,"markets":290,"mutuallyExclusive":117,"openInterest":105,"seriesTicker":81,"slug":314,"status":93,"strikeDate":105,"strikePeriod":105,"subTitle":315,"title":316,"topOutcomes":317,"volume":98,"volume24h":105},"KXFDAAPPROVE-CYT",29,["Date","2026-10-08T14:00:00.000Z"],["Date","2026-09-24T20:31:25.421Z"],[291,298,306],{"ticker":292,"title":293,"yesSubTitle":249,"noSubTitle":249,"yesBidDollars":206,"yesAskDollars":173,"noBidDollars":176,"noAskDollars":205,"lastPriceDollars":294,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":252,"expirationTime":253,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":295,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":296,"spreadCents":38,"spreadQuality":297,"liquidityScore":98},"KXFDAAPPROVE-CYT-26OCT01","Will the FDA approve cytisinicline for smoking cessation before Oct 1, 2026?",0.06,"If the FDA approves cytisinicline for smoking cessation for marketing before Oct 1, 2026, then the market resolves to Yes.",0.05,"moderate",{"ticker":299,"title":300,"yesSubTitle":172,"noSubTitle":172,"yesBidDollars":301,"yesAskDollars":302,"noBidDollars":303,"noAskDollars":304,"lastPriceDollars":301,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":177,"expirationTime":178,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":305,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":301,"spreadCents":31,"spreadQuality":297,"liquidityScore":98},"KXFDAAPPROVE-CYT-27JAN01","Will the FDA approve cytisinicline for smoking cessation before Jan 1, 2027?",0.13,0.17,0.83,0.87,"If the FDA approves cytisinicline for smoking cessation for marketing before Jan 1, 2027, then the market resolves to Yes.",{"ticker":307,"title":308,"yesSubTitle":121,"noSubTitle":121,"yesBidDollars":309,"yesAskDollars":205,"noBidDollars":206,"noAskDollars":310,"lastPriceDollars":194,"volumeFp":98,"volume24hFp":98,"openInterestFp":98,"liquidityDollars":98,"status":93,"result":105,"closeTime":123,"expirationTime":124,"marketType":113,"strikeType":114,"floorStrike":105,"capStrike":105,"rulesPrimary":311,"canCloseEarly":116,"fractionalTradingEnabled":117,"previousPriceDollars":312,"spreadCents":313,"spreadQuality":146,"liquidityScore":98},"KXFDAAPPROVE-CYT-27JUL01","Will the FDA approve cytisinicline for smoking cessation before Jul 1, 2027?",0.19,0.81,"If the FDA approves cytisinicline for smoking cessation for marketing before Jul 1, 2027, then the market resolves to Yes.",0.4,79,"will-the-fda-approve-cytisinicline-for-smoking-cessation-kxfdaapprove-cyt","cytisinicline for smoking cessation","Will the FDA approve cytisinicline for smoking cessation?",[318,320,322],{"name":308,"probability":319,"ticker":307,"volume":98},0.585,{"name":300,"probability":321,"ticker":299,"volume":98},0.15000000000000002,{"name":293,"probability":323,"ticker":292,"volume":98},0.045000000000000005]